Abstract To assess the effectiveness and safety of EUS-BD in patients with jaundice due to malignant biliary obstruction and post-surgically altered anatomy of the upper GI tract who failed prior ERC. Over a defined study period, all consecutive patients, who had undergone EUS-BD, were analyzed retrospectively using a computer-based registry. Overall, 118 patients were registered (mean age, 69 range, 38–88 years; sex ratio f:m, 71:47) from 2005–2020. Technical and clinical success rates were 92.4 % and 93.6 %, respectively. 103 self-expandable metallic stents (SEMS), 2 lumen-apposing metal stents (LAMS), and 22 plastic stents were used. The successful access routes to the bile duct system were trans-gastric (n=69), trans-jejunal (n=39), and trans-esophageal (n=2). Adverse events (AE) occurred in 19.5 % and re-interventions were necessary in 27.9 % of cases. The median post-interventional survival time was 85 (95% CI: 45–256) days. The following parameters were associated with a significantly shorter survival time: CRP > 50 mg/L, bilirubin serum level > 200 µmol/L, high tumor burden, Karnofsky index < 80, and manifest malnutrition status. EUS-BD in malignant biliary obstruction is a safe and effective method, even with surgically altered anatomy of the upper GI tract, in experienced hands of interventional EUS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sabine Thuemer
Frank Meyer
Frank Fueldner
Zeitschrift für Gastroenterologie
Otto-von-Guericke University Magdeburg
University Hospital Magdeburg
SRH Wald-Klinikum Gera
Building similarity graph...
Analyzing shared references across papers
Loading...
Thuemer et al. (Wed,) studied this question.
www.synapsesocial.com/papers/68e861857ef2f04ca37e39a6 — DOI: https://doi.org/10.1055/a-2644-0656